• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用多组学方法了解皮肌炎/多发性肌炎。

Using multi-omics methods to understand dermatomyositis/polymyositis.

机构信息

Department of Rheumatology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan 410008, People's Republic of China.

Department of Pathophysiology, Xiangya School of Medicine, Central South University, 110 Xiangya Road, Changsha, Hunan 410008, People's Republic of China.

出版信息

Autoimmun Rev. 2017 Oct;16(10):1044-1048. doi: 10.1016/j.autrev.2017.07.021. Epub 2017 Aug 1.

DOI:10.1016/j.autrev.2017.07.021
PMID:28778709
Abstract

Idiopathic inflammatory myopathies (IIM) are a group of rare and heterogeneous autoimmune diseases, and the most common subtypes are dermatomyositis (DM) and polymyositis (PM). Despite extensive efforts, the underlying mechanism of IIM remains unclear. Recent efforts to understand the pathogenesis of IIM have included genomics, epigenetics, transcriptomics, proteomics and autoantibody studies. This review focuses on recent studies in DM/PM research based on multi-omics. This integrated analysis of multi-omics profiling will provide useful insights into DM/PM pathogenesis and recommendations for therapeutic targets and biomarkers development.

摘要

特发性炎性肌病(IIM)是一组罕见且异质性的自身免疫性疾病,最常见的亚型是皮肌炎(DM)和多发性肌炎(PM)。尽管已经做了大量努力,但是 IIM 的潜在机制仍不清楚。最近,为了理解 IIM 的发病机制,人们已经进行了基因组学、表观遗传学、转录组学、蛋白质组学和自身抗体研究。这篇综述重点关注基于多组学的 DM/PM 研究的最新研究。对多组学图谱的综合分析将为 DM/PM 的发病机制提供有用的见解,并为治疗靶点和生物标志物的开发提供建议。

相似文献

1
Using multi-omics methods to understand dermatomyositis/polymyositis.利用多组学方法了解皮肌炎/多发性肌炎。
Autoimmun Rev. 2017 Oct;16(10):1044-1048. doi: 10.1016/j.autrev.2017.07.021. Epub 2017 Aug 1.
2
[Advances in epigenetic markers of dermatomyositis/polymyositis].[皮肌炎/多肌炎表观遗传标志物的研究进展]
Beijing Da Xue Xue Bao Yi Xue Ban. 2019 Apr 18;51(2):374-377. doi: 10.19723/j.issn.1671-167X.2019.02.035.
3
Metabolic profiling of patients with different idiopathic inflammatory myopathy subtypes reveals potential biomarkers in plasma.对不同特发性炎性肌病亚型患者的代谢组学分析揭示了血浆中的潜在生物标志物。
Clin Exp Med. 2023 Nov;23(7):3417-3429. doi: 10.1007/s10238-023-01073-6. Epub 2023 Apr 27.
4
Idiopathic inflammatory myopathies.特发性炎性肌病。
Semin Neurol. 2012 Jul;32(3):227-36. doi: 10.1055/s-0032-1329201. Epub 2012 Nov 1.
5
Dermatomyositis and polymyositis: from immunopathology to immunotherapy (immunobiologics).皮肌炎和多发性肌炎:从免疫病理学至免疫治疗(免疫生物制剂)
Rev Bras Reumatol. 2013 Feb;53(1):101-10. doi: 10.1016/s2255-5021(13)70010-5.
6
[Recent research developments in polymyositis/dermatomyositis].
Nihon Rinsho Meneki Gakkai Kaishi. 2008 Apr;31(2):85-92. doi: 10.2177/jsci.31.85.
7
[Intravenous immunoglobulins in polymyositis and dermatomyositis].[静脉注射免疫球蛋白治疗多发性肌炎和皮肌炎]
Rev Med Interne. 1999;20 Suppl 4:436s-439s. doi: 10.1016/s0248-8663(00)88675-0.
8
[Idiopathic inflammatory myopathies: main clinical and immunological variants, difficulties of differential diagnostics and therapy].[特发性炎性肌病:主要临床和免疫变异型、鉴别诊断及治疗难点]
Klin Med (Mosk). 2014;92(3):19-25.
9
The possible role of physical exercise on the treatment of idiopathic inflammatory myopathies.体育锻炼在特发性炎性肌病治疗中的可能作用。
Autoimmun Rev. 2009 Mar;8(5):355-9. doi: 10.1016/j.autrev.2008.11.008. Epub 2008 Nov 28.
10
Integrated comparison of the miRNAome and mRNAome in muscles of dermatomyositis and polymyositis reveals common and specific miRNA-mRNAs.皮肌炎和多发性肌炎肌肉中 miRNA 组学和 mRNA 组学的综合比较揭示了常见和特异的 miRNA-mRNAs。
Epigenomics. 2019 Jan;11(1):23-33. doi: 10.2217/epi-2018-0064. Epub 2018 Dec 7.

引用本文的文献

1
Altered metabolic profiles of dermatomyositis with different myositis-specific autoantibodies associated with clinical phenotype.伴不同肌炎特异性自身抗体的皮肌炎代谢谱改变与临床表型相关。
Front Immunol. 2024 Nov 25;15:1429010. doi: 10.3389/fimmu.2024.1429010. eCollection 2024.
2
Identification and validation of interferon-stimulated gene 15 as a biomarker for dermatomyositis by integrated bioinformatics analysis and machine learning.通过整合生物信息学分析和机器学习鉴定和验证干扰素刺激基因 15 作为皮肌炎的生物标志物。
Front Immunol. 2024 Nov 4;15:1429817. doi: 10.3389/fimmu.2024.1429817. eCollection 2024.
3
Pathogenic role and clinical significance of neutrophils and neutrophil extracellular traps in idiopathic inflammatory myopathies.
中性粒细胞和中性粒细胞胞外诱捕网在特发性炎性肌病中的致病作用及临床意义。
Clin Exp Med. 2024 May 30;24(1):115. doi: 10.1007/s10238-024-01384-2.
4
Explore the shared molecular mechanism between dermatomyositis and nasopharyngeal cancer by bioinformatic analysis.通过生物信息学分析探讨皮肌炎和鼻咽癌之间的共同分子机制。
PLoS One. 2024 May 16;19(5):e0296034. doi: 10.1371/journal.pone.0296034. eCollection 2024.
5
Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach.采用生物信息学方法对皮肌炎、多发性肌炎和dysferlinopathy患者的骨骼肌进行转录组分析。
Front Neurol. 2023 Dec 6;14:1328547. doi: 10.3389/fneur.2023.1328547. eCollection 2023.
6
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress.抗 MDA5 抗体阳性皮肌炎:发病机制与临床进展。
Nat Rev Rheumatol. 2024 Jan;20(1):48-62. doi: 10.1038/s41584-023-01054-9. Epub 2023 Dec 6.
7
Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease.伴有间质性肺病的特发性炎性肌病进展的预测因素。
J Transl Int Med. 2022 Nov 15;11(1):46-56. doi: 10.2478/jtim-2022-0029. eCollection 2023 Mar.
8
Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.皮肌炎和免疫介导性坏死性肌病的病理生理机制与治疗:重点综述。
Int J Mol Sci. 2022 Apr 13;23(8):4301. doi: 10.3390/ijms23084301.
9
The Role of Myositis-Specific Autoantibodies in the Dermatomyositis Spectrum.肌炎特异性自身抗体在皮肌炎谱系中的作用
Cureus. 2022 Mar 8;14(3):e22978. doi: 10.7759/cureus.22978. eCollection 2022 Mar.
10
miR-18a-3p and Its Target Protein HuR May Regulate Myogenic Differentiation in Immune-Mediated Necrotizing Myopathy.miR-18a-3p 及其靶蛋白 HuR 可能调节免疫介导的坏死性肌病中的成肌分化。
Front Immunol. 2022 Jan 5;12:780237. doi: 10.3389/fimmu.2021.780237. eCollection 2021.